Management of Digoxin Toxicity
Administer digoxin-specific antibody fragments (digoxin-Fab) immediately for life-threatening digoxin toxicity, which includes ventricular arrhythmias, progressive bradyarrhythmias, heart block, or hyperkalemia. This is a Class 1 recommendation with strong evidence showing 50-90% response rates and dysrhythmia resolution within 30-45 minutes 1.
Primary Treatment Algorithm
Step 1: Discontinue Digoxin and Assess Severity
- Immediately stop digoxin in all cases 2
- Identify life-threatening manifestations:
- Ventricular tachycardia or ventricular fibrillation
- Progressive bradyarrhythmias or heart block
- Hyperkalemia (particularly >5.5 mmol/L in acute toxicity)
- Serum digoxin >10 ng/mL
- Ingestion >10 mg in adults or >4 mg in children 2
Critical point: Toxicity can occur at therapeutic serum concentrations (even 1.4 ng/mL), especially with hypokalemia, hypomagnesemia, hypercalcemia, or renal impairment 3. Clinical features trump serum levels in diagnosis.
Step 2: Digoxin-Fab Administration
For life-threatening toxicity: Administer digoxin-Fab without delay—do not wait for confirmatory serum levels 1, 4. Observational data shows 54% survival in cardiac arrest cases treated with digoxin-Fab 1.
Dosing approach:
- Life-threatening toxicity: Full neutralizing dose based on body load calculation or empiric dosing
- Non-life-threatening chronic toxicity: Lower doses (40 mg has shown efficacy) 3
- Response typically occurs within 30-45 minutes 1
Step 3: Manage Specific Arrhythmias
For bradydysrhythmias:
- Atropine may be reasonable (Class 2b recommendation) 1
- Temporary pacing may be reasonable but carries 36% complication rate 1
- Caution: Pacing is temporizing only while awaiting digoxin-Fab effect 1
For ventricular dysrhythmias:
- Lidocaine or phenytoin may be reasonable as bridge therapy until digoxin-Fab administered (Class 2b) 1
- Bretylium is no longer manufactured 1
Step 4: Electrolyte Management
Potassium:
- Maintain serum potassium 4.0-5.5 mmol/L in non-massive overdose 2
- In massive overdose with hyperkalemia: Do NOT give potassium—this is life-threatening 2
- Hyperkalemia from massive toxicity requires digoxin-Fab as primary treatment; glucose-insulin may be needed acutely 2
- Avoid potassium in bradycardia/heart block unless related to supraventricular tachycardia 2
Magnesium:
- Correct hypomagnesemia as it sensitizes myocardium to digoxin toxicity 2
Step 5: Gastrointestinal Decontamination (Acute Ingestion Only)
Within 30 minutes of presentation:
If >2 hours post-ingestion or toxic manifestations present:
- Avoid gastric manipulation—may trigger vagal episode worsening arrhythmias 2
Activated charcoal:
- Large doses recommended to prevent absorption and bind digoxin during enterohepatic recirculation 2
What NOT to Do
Do not use extracorporeal removal (hemodialysis, hemofiltration, hemoperfusion, plasmapheresis)—Class 3 recommendation due to digoxin's large volume of distribution 1. Exception: Hemoperfusion may be considered in renal insufficiency to enhance elimination 5.
Common Pitfalls
Relying solely on serum digoxin levels: Toxicity occurs at therapeutic levels with electrolyte abnormalities or renal impairment 3, 6
Giving potassium in massive overdose: Causes life-threatening hyperkalemia from intracellular potassium shift 2
Delaying digoxin-Fab for confirmatory testing: Treat immediately based on clinical presentation 4
Using calcium in digitalized patients: Rapid IV calcium causes serious arrhythmias 2
Aggressive gastric decontamination after 2 hours: Vagal stimulation worsens arrhythmias 2
Special Populations
Renal impairment: Higher toxicity risk due to prolonged elimination; toxic effects last longer; requires smaller maintenance doses 2
Elderly patients: Account for 88% of toxicity cases; increased susceptibility 7
Acute myocardial infarction: Use digoxin-Fab cautiously as inotropic effects may increase oxygen demand 2